Status:
COMPLETED
DuoTrav® Eye Drops As Replacement Therapy Program
Lead Sponsor:
Alcon Research
Conditions:
Open-angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To evaluate the effectiveness of DuoTrav Eye Drops in gaining or maintaining control of target Intraocular Pressures (tIOP) in patients diagnosed with, and being treated for, open-angle glaucoma (OAG)...
Eligibility Criteria
Inclusion
- Patients with OAG or OH for whom single agent therapy provides insufficient intraocular pressure reduction
Exclusion
- None
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT00828906
Start Date
February 1 2009
Last Update
September 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Alcon for Trial Locations
Beijing, China